Analyst firms · Robert W. Baird · RPHM

Robert W. Baird RPHM price target and rating history

Reneo Pharmaceuticals Inc. (RPHM) · Health Care

Robert W. Baird rates Reneo Pharmaceuticals Inc. (RPHM) Neutral with a $3 price target, as of its latest action on Dec 14, 2023. It has published 3 rating actions on RPHM since January 2022, including 0 upgrades and 1 downgrade.

Current rating
Neutral
Price target
$3
Median target, all firms
Too few
Actions on RPHM
3

Robert W. Baird price target on RPHM

$28$16$32023202420252026
Robert W. Baird price target on RPHM, each point a stated target, January 2022 to December 2023.

Every Robert W. Baird rating on RPHM

Questions about Robert W. Baird and RPHM

What is Robert W. Baird's price target for RPHM?
Robert W. Baird's latest stated price target for Reneo Pharmaceuticals Inc. (RPHM) is $3, from its action on Dec 14, 2023.
What is Robert W. Baird's rating on RPHM?
Robert W. Baird rates RPHM Neutral, a neutral rating, as of Dec 14, 2023.
When did Robert W. Baird last change its view on RPHM?
On Dec 14, 2023, Robert W. Baird downgrades to Neutral from Outperform, price target $28 to $3.

More RPHM rating histories

All Robert W. Baird ratingsRPHM news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.